P573-7103 Screening compound: 2-[3-oxo-7-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]-N-phenylacetamide

P573-7103 Screening compound: 2-[3-oxo-7-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]-N-phenylacetamide
P573-7103 Screening compound: 2-[3-oxo-7-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P573-7103
2-[3-oxo-7-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P573-7103

Molecular Formula

C17H18N6O2S (C17 H18 N6 O2 S)

Compound Name

2-[3-oxo-7-(thiomorpholin-4-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-2-yl]-N-phenylacetamide

IUPAC name

2-[3-oxo-7-(thiomorpholin-4-yl)-2H3H-[124]triazolo[43-a]pyrimidin-2-yl]-N-phenylacetamide

SMILES

O=C(CN(C(N1C=C2)=O)N=C1N=C2N1CCSCC1)Nc1ccccc1

InChI

InChI=1S/C17H18N6O2S/c24-15(18-13-4-2-1-3-5-13)12-23-17(25)22-7-6-14(19-16(22)20-23)21-8-10-26-11-9-21/h1-7H,8-12H2,(H,18,24)

InChI Key

PJZSBUBTZYXOBE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27604863

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.132

Distribution Coefficient, logD

1.132

Water Solubility, LogSw

-2.16

Polar Surface Area

68.205

Acid Dissociation Constant (pKa)

13.24

Base Dissociation Constant (pKb)

6.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.40

P573-7103 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P573-7103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P573-7103?
Check Price and Availability of P573-7103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P573-7103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P573-7103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P573-7103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P573-7103 available by request